ARTICLE | Company News
Aronex other research news
October 9, 1995 7:00 AM UTC
Aronex (The Woodlands, Texas) received two Phase I SBIR grants totaling $200,000 from the National Institute of Allergy and Infectious Diseases to study the mechanism of action and pharmacology of AR1...